Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastrointest Endosc. Dec 16, 2022; 14(12): 759-768
Published online Dec 16, 2022. doi: 10.4253/wjge.v14.i12.759
Table 2 Outcomes of the main analysis
Outcomes
Early group (< 24 h)
Elective group (≥ 24 h)
Difference (95%CI)
P value
Primary outcome
Length of hospital stay, days, median (IQR)7 (7–9)8 (7– 9.5)0.10
Secondary outcomes
Identification of stigmata of recent hemorrhage (%)32.5 (62/191)20.9 (40/191)11.6 (2.7 to 20.3)0.02
Rebleeding (%)28.8 (55/191) 24.1 (46/191) 4.7 (-4.1 to 13.5)0.35
Red blood cell transfusion ≥ 4 units (%)29.3 (56/191) 27.7 (53/191) 1.6 (-7.5 to 10.6)0.82
Interventional radiology and abdominal surgery (%)2.1 (4/191)1.6 (3/191)0.5 (-2.2 to 3.2)1.00